1-2 of 2
Martin Schultz
Close
Save search
Sort by
Journal Articles

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

Free
Clinical Trials & Observations
Myron S. Czuczman, Luis Fayad, Vincent Delwail, Guillaume Cartron, Eric Jacobsen, Kazimierz Kuliczkowski, Brian K. Link, Lauren Pinter-Brown, John Radford, Andrzej Hellmann, Eve Gallop-Evans, Christine G. DiRienzo, Nancy Goldstein, Ira Gupta, Roxanne C. Jewell, Thomas S. Lin, Steen Lisby, Martin Schultz, Charlotte A. Russell, Anton Hagenbeek
Journal: Blood
Blood (2012) 119 (16): 3698–3704.
https://doi.org/10.1182/blood-2011-09-378323
Published: 2012
Includes: Supplemental data
Journal Articles

Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma.

Free
Anton Hagenbeek, Luis Fayad, Vincent Delwail, Jean Francois Rossi, Eric Jacobsen, Kazimierz Kuliczkowski, Brian K Link, Lauren Pinter-Brown, John Radford, Andrzej Hellmann, Eve Gallop-Evans, Ira Gupta, Michael Arning, Kamilla Begtrup, Martin Schultz, Bo Bang, Charlotte A Russell, Myron S Czuczman
Journal: Blood
Blood (2009) 114 (22): 935.
https://doi.org/10.1182/blood.V114.22.935.935
Published: 2009